EU Guidance for the Transition of clinical trials from the Clinical Trials Directive to the Clinical Trials Regulation, 07/23 Anastasija Eschricht2023-08-17T08:22:06+00:00August 17th, 2023|
FDA GFI, A Risk-Based Approach to Monitoring of Clinical Investigations, Q&A, 04/23 Anastasija Eschricht2023-07-24T13:39:53+00:00July 24th, 2023|
FDA GFI, Electronic Source Data in Clinical Investigations, 09/13 Anastasija Eschricht2023-07-24T13:15:09+00:00July 24th, 2023|
ICH Guideline, Good Clinical Practice (GCP), E6(R3), DRAFT, 05/23 Anastasija Eschricht2023-07-24T13:11:24+00:00July 24th, 2023|
FDA GFI, Digital Health Technologies for Remote Data Acquisition in Clinical Investigations, DRAFT, 12/21 Anastasija Eschricht2023-06-27T11:50:00+00:00June 27th, 2023|
FDA GFI, Decentralized Clinical Trials for Drugs, Biological Products, and Devices, DRAFT, 05/23 Anastasija Eschricht2023-06-27T09:52:58+00:00June 27th, 2023|